Literature DB >> 23238524

Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.

Fumitoshi Kodaka1, Hiroshi Ito, Yasuyuki Kimura, Saori Fujie, Harumasa Takano, Hironobu Fujiwara, Takeshi Sasaki, Kazuhiko Nakayama, Christer Halldin, Lars Farde, Tetsuya Suhara.   

Abstract

PURPOSE: Dopamine D receptors (DRs) have two affinity states for endogenous dopamine, referred to as high-affinity state (D ), which has a high affinity for endogenous dopamine, and low-affinity state (D ). The density of D can be measured with (R)-2-CHO-N-n-propylnorapomorphine ([C]MNPA), while total density of D and D (DRs) can be measured with [C]raclopride using positron emission tomography (PET). Thus, the ratio of the binding potential (BP) of [C]MNPA to that of [C]raclopride ([C]MNPA/[C]raclopride) may reflect the proportion of the density of D to that of DRs. In the caudate and putamen, [C]MNPA/[C]raclopride reflects the proportion of the density of D to that of DRs. To evaluate the reliability of the PET paradigm with [C]MNPA and [C]raclopride, we investigated the test-retest reproducibility of non-displaceable BP (BP ) measured with [C]MNPA and of [C]MNPA/[C]raclopride in healthy humans.
METHODS: Eleven healthy male volunteers underwent two sets of PET studies on separate days that each included [C]MNPA and [C]raclopride scans. BP values in the caudate and putamen were calculated. Test-retest reproducibility of BP of [C]MNPA and [C]MNPA/[C]raclopride was assessed by intra-subject variability (absolute variability) and test-retest reliability (intraclass correlation coefficient: ICC).
RESULTS: The absolute variability of [C]MNPA BP was 5.30 ± 3.96 % and 12.3 ± 7.95 % and the ICC values of [C]MNPA BP were 0.72 and 0.82 in the caudate and putamen, respectively. The absolute variability of [C]MNPA/[C]raclopride was 6.11 ± 3.68 % and 11.60 ± 5.70 % and the ICC values of [C]MNPA/[C]raclopride were 0.79 and 0.80 in the caudate and putamen, respectively.
CONCLUSION: In the present preliminary study, the test-retest reproducibility of BP of [C]MNPA and of [C]MNPA/[C]raclopride was reliable in the caudate and putamen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238524     DOI: 10.1007/s00259-012-2312-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  10 in total

1.  Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.

Authors:  Mette Skinbjerg; Yoon Namkung; Christer Halldin; Robert B Innis; David R Sibley
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

2.  Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.

Authors:  Nicholas Seneca; Sjoerd J Finnema; Lars Farde; Balázs Gulyás; Håkan V Wikström; Christer Halldin; Robert B Innis
Journal:  Synapse       Date:  2006-04       Impact factor: 2.562

3.  Simplified reference tissue model for PET receptor studies.

Authors:  A A Lammertsma; S P Hume
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

4.  Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.

Authors:  Philip Seeman; Alan Wilson; Peter Gmeiner; Shitij Kapur
Journal:  Synapse       Date:  2006-09-01       Impact factor: 2.562

5.  Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.

Authors:  Graham Searle; John D Beaver; Robert A Comley; Massimo Bani; Andri Tziortzi; Mark Slifstein; Manolo Mugnaini; Cristiana Griffante; Alan A Wilson; Emilio Merlo-Pich; Sylvain Houle; Roger Gunn; Eugenii A Rabiner; Marc Laruelle
Journal:  Biol Psychiatry       Date:  2010-08-15       Impact factor: 13.382

6.  Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.

Authors:  A De Lean; B F Kilpatrick; M G Caron
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

7.  Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.

Authors:  Philip Seeman; Teresa Tallerico; Françoise Ko; Catherine Tenn; Shitij Kapur
Journal:  Synapse       Date:  2002-12-15       Impact factor: 2.562

8.  Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.

Authors:  Tatsui Otsuka; Hiroshi Ito; Christer Halldin; Hidehiko Takahashi; Harumasa Takano; Ryosuke Arakawa; Masaki Okumura; Fumitoshi Kodaka; Michie Miyoshi; Mizuho Sekine; Chie Seki; Ryuji Nakao; Kazutoshi Suzuki; Sjoerd Finnema; Yoshio Hirayasu; Tetsuya Suhara; Lars Farde
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

9.  Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.

Authors:  Y G Gao; R J Baldessarini; N S Kula; J L Neumeyer
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

10.  Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.

Authors:  J Hirvonen; S Aalto; V Lumme; K Någren; J Kajander; H Vilkman; N Hagelberg; V Oikonen; J Hietala
Journal:  Nucl Med Commun       Date:  2003-12       Impact factor: 1.690

  10 in total
  13 in total

1.  Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.

Authors:  Aybala Saricicek; Jason Chen; Beata Planeta; Barbara Ruf; Kalyani Subramanyam; Kathleen Maloney; David Matuskey; David Labaree; Lorenz Deserno; Alexander Neumeister; John H Krystal; Jean-Dominique Gallezot; Yiyun Huang; Richard E Carson; Zubin Bhagwagar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-27       Impact factor: 9.236

2.  Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol.

Authors:  Y Kimura; J Maeda; M Yamada; K Takahata; K Yokokawa; Y Ikoma; C Seki; H Ito; M Higuchi; T Suhara
Journal:  Psychopharmacology (Berl)       Date:  2016-10-20       Impact factor: 4.530

3.  Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.

Authors:  Mika Naganawa; Ming-Qiang Zheng; Shannan Henry; Nabeel Nabulsi; Shu-Fei Lin; Jim Ropchan; David Labaree; Soheila Najafzadeh; Michael Kapinos; Johannes Tauscher; Alexander Neumeister; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2015-01-15       Impact factor: 10.057

4.  Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.

Authors:  Jean-Dominique Gallezot; Ming-Qiang Zheng; Keunpoong Lim; Shu-fei Lin; David Labaree; David Matuskey; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Robert T Malison
Journal:  J Nucl Med       Date:  2014-04-14       Impact factor: 10.057

5.  Dual time-point imaging for post-dose binding potential estimation applied to a [11C]raclopride PET dose occupancy study.

Authors:  Isadora Lopes Alves; Antoon Tm Willemsen; Rudi A Dierckx; Ana Maria M da Silva; Michel Koole
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

6.  Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.

Authors:  N D Volkow; G-J Wang; J Logan; D Alexoff; J S Fowler; P K Thanos; C Wong; V Casado; S Ferre; D Tomasi
Journal:  Transl Psychiatry       Date:  2015-04-14       Impact factor: 6.222

7.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

8.  Statistical evaluation of test-retest studies in PET brain imaging.

Authors:  Richard Baumgartner; Aniket Joshi; Dai Feng; Francesca Zanderigo; R Todd Ogden
Journal:  EJNMMI Res       Date:  2018-02-12       Impact factor: 3.138

9.  In vivo imaging of D2 receptors and corticosteroids predict behavioural responses to captivity stress in a wild bird.

Authors:  Christine R Lattin; Devin P Merullo; Lauren V Riters; Richard E Carson
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

10.  Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.

Authors:  Manabu Kubota; Tomohisa Nagashima; Harumasa Takano; Fumitoshi Kodaka; Hironobu Fujiwara; Keisuke Takahata; Sho Moriguchi; Yasuyuki Kimura; Makoto Higuchi; Yoshiro Okubo; Hidehiko Takahashi; Hiroshi Ito; Tetsuya Suhara
Journal:  Int J Neuropsychopharmacol       Date:  2017-11-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.